Rafferty Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Rafferty Asset Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-276,787	Closed	-$7.46M	–	1177
2022 Q4	$7.46M	Buy	276,787 +114,534	+71%	+$3.01M	0.06%	282
2022 Q3	$2.91M	Buy	162,253 +56,882	+54%	+$908K	0.03%	423
2022 Q2	$1.31M	Sell	105,371 -165,686	-61%	-$1.83M	0.01%	569
2022 Q1	$3.61M	Buy	271,057 +18,867	+7%	+$253K	0.02%	457
2021 Q4	$3.93M	Buy	252,190 +138,428	+122%	+$2.64M	0.02%	469
2021 Q3	$2.55M	Sell	113,762 -1,657	-1%	-$36.4K	0.02%	558
2021 Q2	$2.63M	Buy	+115,419	New	+$2.43M	0.02%	565

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rafferty Asset Management's MYOV Position: Q1 2023 in Review

Rafferty Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 276,787 shares — an estimated $7.46M sold.

Rafferty Asset Management first reported a position in MYOV in Q2 2021 and held it in 7 quarters. The position peaked at $7.46M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Rafferty Asset Management reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Rafferty Asset Management sold 276,787 Myovant Sciences Ltd. shares in Q1 2023, an estimated $7.46M.
Rafferty Asset Management first reported a position in Myovant Sciences Ltd. in Q2 2021 and held it in 7 quarters.
Rafferty Asset Management's Myovant Sciences Ltd. position peaked at $7.46M in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Rafferty Asset Management's 13F filing for Q1 2023, filed 11 May 2023.